Annual report
2503.TEDINET S100YT3M
Period2025-01-01 → 2025-12-31
Filed2026-08-03
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Amends S100XTVS. Amended by S100YTSJ (2026-08-03).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.43T | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.34T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.13T | 2023-01-01 → 2023-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.99T | 2022-01-01 → 2022-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.82T | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥209.7bn | 2025-01-01 → 2025-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥125.3bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥237.9bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥139.7bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥197.0bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥191.4bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥99.6bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥147.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥58.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥111.0bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥59.8bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥178.2bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥85.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.49T | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.35T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.87T | at 2023-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.54T | at 2022-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.47T | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.90T | at 2025-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.82T | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.60T | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.53T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.29T | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.18T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.13T | at 2023-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥980.0bn | at 2022-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥894.2bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥125.3bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.1bn | at 2022-12-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥149.5bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥295.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥242.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥203.2bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥135.6bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥219.3bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥185.0bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥329.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥226.1bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥10.4bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥56.4bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥110.5bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥58.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥35.9bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥167.8bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥180.5bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥182.13 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥71.87 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥139.16 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥135.08 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥71.73 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥182.13 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥71.86 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥139.15 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥135.07 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥71.7 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,588.59 | at 2025-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,458.68 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,398.47 | at 2023-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,210.16 | at 2022-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,072.69 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 36.8% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 35.2% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.5% | at 2023-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 38.5% | at 2022-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 36.2% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 12.0% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.0% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 10.7% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 11.8% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 31,144 | at 2025-12-31 | Cons. | Number of employees |
| Revenue | ¥144.4bn | 2025-01-01 → 2025-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥194.6bn | 2024-01-01 → 2024-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥139.0bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥152.8bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥139.5bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥56.0bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥114.5bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥48.1bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥60.4bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥62.2bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥76.9bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥73.8bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥47.9bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥332.2bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥48.0bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥344.9bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥70.4bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥48.7bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥77.3bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.97T | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥1.85T | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥2.28T | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.90T | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.00T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.42T | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.29T | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥551.3bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥561.9bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥964.2bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥951.1bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.01T | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥23.6bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥12.2bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥59.28 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-425.84 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.91 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.24 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥92.67 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥74 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥71 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥71 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥69 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥680.54 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥693.7 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,190.61 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,174.47 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,208.06 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 28.0% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.4% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.6% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -45.2% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.0% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 914,000,000 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,124 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 1,067 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 977 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 914 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 1,156 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 75
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2025-01-01 → 2025-12-31 | ¥9.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-12-31 | 2200 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-12-31 | ¥101.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-12-31 | ¥32.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥69.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-12-31 | ¥417.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥10.0bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥79.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥79.4bn |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | −¥542.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥63.6bn |
| Alcoholic Beveragesreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥50.5bn |
| Alcoholic Beveragesreportable segment | employees | at 2025-12-31 | 8800 pure |
| Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥1.08T |
| Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥1.08T |
| Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥2.1bn |
| Alcoholic Beveragesreportable segment | segment assets | at 2025-12-31 | ¥1.43T |
| Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥135.4bn |
| Health Sciencereportable segment | capex | 2025-01-01 → 2025-12-31 | ¥12.7bn |
| Health Sciencereportable segment | employees | at 2025-12-31 | 5643 pure |
| Health Sciencereportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥256.1bn |
| Health Sciencereportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥251.4bn |
| Health Sciencereportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥4.7bn |
| Health Sciencereportable segment | segment assets | at 2025-12-31 | ¥764.1bn |
| Health Sciencereportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥11.1bn |
| Non Alcoholic Beveragesreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥19.7bn |
| Non Alcoholic Beveragesreportable segment | employees | at 2025-12-31 | 7849 pure |
| Non Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥581.5bn |
| Non Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥578.2bn |
| Non Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥3.3bn |
| Non Alcoholic Beveragesreportable segment | segment assets | at 2025-12-31 | ¥364.7bn |
| Non Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥67.7bn |
| Pharmaceuticalsreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥93.7bn |
| Pharmaceuticalsreportable segment | employees | at 2025-12-31 | 5161 pure |
| Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥496.8bn |
| Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥496.5bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥312m |
| Pharmaceuticalsreportable segment | segment assets | at 2025-12-31 | ¥1.06T |
| Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥102.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-01-01 → 2024-12-31 | ¥7.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-12-31 | ¥97.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-12-31 | ¥21.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥76.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-12-31 | ¥362.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-12-31 | ¥30m |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥10.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥86.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥86.4bn |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | −¥478.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥58.0bn |
| Alcoholic Beveragesreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥39.0bn |
| Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥1.08T |
| Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥1.08T |
| Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥2.3bn |
| Alcoholic Beveragesreportable segment | segment assets | at 2024-12-31 | ¥1.37T |
| Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥124.0bn |
| Health Sciencereportable segment | capex | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Health Sciencereportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥179.5bn |
| Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥175.3bn |
| Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥4.2bn |
| Health Sciencereportable segment | segment assets | at 2024-12-31 | ¥764.1bn |
| Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥10.9bn |
| Non Alcoholic Beveragesreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥20.9bn |
| Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥567.8bn |
| Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥564.9bn |
| Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥3.0bn |
| Non Alcoholic Beveragesreportable segment | segment assets | at 2024-12-31 | ¥326.4bn |
| Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥64.0bn |
| Pharmaceuticalsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥109.5bn |
| Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥495.6bn |
| Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥495.3bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥264m |
| Pharmaceuticalsreportable segment | segment assets | at 2024-12-31 | ¥1.01T |
| Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥91.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,405
| Item | Context | Value | Unit |
|---|---|---|---|
| Equity IFRS | CurrentYearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | 210785000000 | JPY |
| Equity IFRS | CurrentYearInstant_EffectivePortionOfCashFlowHedgesIFRSMember | 238000000 | JPY |
| Equity IFRS | CurrentYearInstant_OtherComponentsOfEquityIFRSMember | 234858000000 | JPY |
| Equity IFRS | CurrentYearInstant_EquityAttributableToOwnersOfParentIFRSMember | 1286991000000 | JPY |
| Equity IFRS | CurrentYearInstant_NonControllingInterestsIFRSMember | 308156000000 | JPY |
| Equity IFRS | CurrentYearInstant | 1595148000000 | JPY |
| Profit loss before tax IFRS | Prior1YearDuration | 139721000000 | JPY |
| Profit loss before tax IFRS | CurrentYearDuration | 237859000000 | JPY |
| Depreciation and amortization ope cf IFRS | Prior1YearDuration | 95702000000 | JPY |
| Depreciation and amortization ope cf IFRS | CurrentYearDuration | 101850000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | Prior1YearDuration | 13389000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | CurrentYearDuration | 6175000000 | JPY |
| Interest and dividend income ope cf IFRS | Prior1YearDuration | -11103000000 | JPY |
| Interest and dividend income ope cf IFRS | CurrentYearDuration | -8395000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1YearDuration | -37035000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | CurrentYearDuration | -35830000000 | JPY |
| Interest expenses ope cf IFRS | Prior1YearDuration | 6916000000 | JPY |
| Interest expenses ope cf IFRS | CurrentYearDuration | 11029000000 | JPY |
| Loss gain on step acquisition ope cf IFRS | Prior1YearDuration | 18265000000 | JPY |
| Loss gain on step acquisition ope cf IFRS | CurrentYearDuration | － | JPY |
| Gain on sale of property plant and equipment and intangible assets ope cf IFRS | Prior1YearDuration | -3713000000 | JPY |
| Gain on sale of property plant and equipment and intangible assets ope cf IFRS | CurrentYearDuration | -3351000000 | JPY |
| Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRS | Prior1YearDuration | 4925000000 | JPY |
| Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRS | CurrentYearDuration | 3793000000 | JPY |
| Gain on sales of subsidiaries ope cf IFRS | Prior1YearDuration | -7372000000 | JPY |
| Gain on sales of subsidiaries ope cf IFRS | CurrentYearDuration | － | JPY |
| Impairment charges of investments accounted for using equity method ope cf IFRS | Prior1YearDuration | 19255000000 | JPY |
| Impairment charges of investments accounted for using equity method ope cf IFRS | CurrentYearDuration | － | JPY |
| Decrease increase in trade receivables ope cf IFRS | Prior1YearDuration | -34894000000 | JPY |
| Decrease increase in trade receivables ope cf IFRS | CurrentYearDuration | -33345000000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1YearDuration | -4888000000 | JPY |
| Decrease increase in inventories ope cf IFRS | CurrentYearDuration | -1735000000 | JPY |
| Increase decrease in trade payables ope cf IFRS | Prior1YearDuration | 18240000000 | JPY |
| Increase decrease in trade payables ope cf IFRS | CurrentYearDuration | 3098000000 | JPY |
| Increase decrease in liquor taxes payable ope cf IFRS | Prior1YearDuration | 1942000000 | JPY |
| Increase decrease in liquor taxes payable ope cf IFRS | CurrentYearDuration | 44000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YearDuration | 43977000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYearDuration | 20505000000 | JPY |
| Subtotal ope cf IFRS | Prior1YearDuration | 263325000000 | JPY |
| Subtotal ope cf IFRS | CurrentYearDuration | 301698000000 | JPY |
| Interest and dividends received ope cf IFRS | Prior1YearDuration | 36852000000 | JPY |
| Interest and dividends received ope cf IFRS | CurrentYearDuration | 36594000000 | JPY |
| Interest paid ope cf IFRS | Prior1YearDuration | -6522000000 | JPY |
| Interest paid ope cf IFRS | CurrentYearDuration | -9884000000 | JPY |
| Income taxes paid ope cf IFRS | Prior1YearDuration | -50811000000 | JPY |
| Income taxes paid ope cf IFRS | CurrentYearDuration | -32980000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YearDuration | 242844000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYearDuration | 295428000000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf IFRS | Prior1YearDuration | -180584000000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf IFRS | CurrentYearDuration | -175592000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |